The University of Tokyo, RIKEN, Nichi-Iko and Daiichi Sankyo Reach Basic Agreement on Collaborative R&D on Nafamostat Inhalation Formulation for Treatment of Novel Corona Virus Infection (COVID-19)
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.daiichisankyo.com/files/news/pressrelease/pdf/007148/20200608_E.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
